side effects of stopping glp 1 Taking GLP‑1 Without Diabetes in 2026: What Real People Notice After 3, 6 and 12 Months GLP-1 and Low Blood Pressure:

Injection technique Finding the best injection site for semaglutide makes the experience significantly more comfortable

This is a clinic that gets the day-to-day patient experience right

Clinical studies have shown that tirzepatide can lead to significant weight loss in adults with obesity or overweight, even in people without diabetes

Dementia Too

Acceptability and accuracy of a non-endoscopic screening test for Barretts oesophagus in primary care: cohort study

In 2025, the European Medicines Agency concluded that NAION should be listed as a very rare side effect of semaglutide medications, including Ozempic, Wegovy, and Rybelsus, after reviewing clinical studies, adverse event reports, and post-market safety data